Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2020-08-01 2020-07-31
Drug Identification Number 02242441 02242441
Brand name PUREGON PUREGON
Common or Proper name follitropin beta Solution for injection follitropin beta Solution for injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients FOLLITROPIN BETA FOLLITROPIN BETA
Strength(s) 100UNIT 100UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS
Packaging size 100IU/0.5ML 5X0.5ML 100IU/0.5ML 5X0.5ML
ATC code G03GA G03GA
ATC description GONADOTROPHINS AND OTHER OVULATION STIMULANTS GONADOTROPHINS AND OTHER OVULATION STIMULANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-07-31 2020-07-31
Actual discontinuation date 2020-07-31 2020-07-31
Remaining supply date 2020-07-31 2020-07-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments